3.
肺腺癌患者生存期影响因素的Cox回归模型分析结果
Univariate and multivariate analysis of clinicopathological factors for the overall survival rate of 126 patients with lung adenocarcinoma
| Parameter | β | S.E. | Wald | Exp(B) | 95%CI for Exp(B) | P | |
| Lower Upper | |||||||
| Univariate analysis | |||||||
| Gender | 0.024 | 0.220 | 0.012 | 1.025 | 0.666 | 1.577 | 0.912 |
| Age | 0.481 | 0.225 | 4.572 | 1.618 | 1.041 | 2.516 | 0.032* |
| Smoking status | 0.104 | 0.220 | 0.222 | 1.109 | 0.721 | 1.708 | 0.637 |
| Tumor size | -0.014 | 0.229 | 0.004 | 0.986 | 0.630 | 1.544 | 0.952 |
| Pathological stage | 0.346 | 0.145 | 5.673 | 1.414 | 1.063 | 1.879 | 0.017* |
| T stage | 0.077 | 0.183 | 0.176 | 1.080 | 0.754 | 1.547 | 0.675 |
| N stage | 0.297 | 1.141 | 4.430 | 1.345 | 1.021 | 1.773 | 0.035 |
| Differentiation | 0.086 | 0.189 | 0.209 | 1.090 | 0.753 | 1.578 | 0.647 |
| Metastasis | -4.210 | 1.014 | 17.236 | 0.015 | 0.002 | 0.108 | < 0.001 |
| Chemotherapy efficacy | -0.274 | 0.113 | 5.841 | 0.760 | 0.609 | 0.949 | 0.016 |
| OCT4 | -0.815 | 0.291 | 7.813 | 0.443 | 0.250 | 0.784 | 0.005 |
| Multivariate analysis | |||||||
| Metastasis | -6.212 | 1.150 | 29.201 | 0.002 | 0.000 | 0.019 | < 0.001 |
| OCT4 | 0.898 | 0.332 | 7.307 | 2.455 | 1.280 | 4.709 | 0.007 |
| Chemotherapy efficacy | 0.867 | 0.178 | 23.791 | 2.380 | 1.680 | 3.372 | < 0.001 |
| Pathological stage | 0.495 | 0.336 | 2.167 | 1.640 | 0.849 | 3.169 | 0.141 |
| N stage | -0.623 | 0.333 | 3.502 | 0.536 | 0.279 | 1.030 | 0.061 |
| Age | 0.195 | 0.256 | 0.581 | 0.215 | 0.736 | 2.005 | 0.446 |